REFRACTORY METASTATIC COLORECTAL CANCER
Clinical trials for REFRACTORY METASTATIC COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY METASTATIC COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for REFRACTORY METASTATIC COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo targets liver tumors in hard-to-treat colorectal cancer
Disease control Recruiting nowThis study tests whether giving a strong chemotherapy directly to the liver, followed by standard cancer pills and an injection, works better than the standard treatment alone. It is for people whose colorectal cancer has spread mostly to the liver and is no longer responding to …
Matched conditions: REFRACTORY METASTATIC COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Delcath Systems Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for Tough-to-Treat colorectal cancer: experimental combo enters Late-Stage trial
Disease control Recruiting nowThis phase 3 trial is testing whether adding the experimental drug suvemcitug to standard chemotherapy (trifluridine/tipiracil) helps people with metastatic colorectal cancer that no longer responds to other treatments live longer. About 464 participants will receive either the c…
Matched conditions: REFRACTORY METASTATIC COLORECTAL CANCER
Phase: PHASE3 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC